Santodomingo-Garzon Tania, Han Jinglan, Le Tai, Yang Yang, Swain Mark G
From the Immunology Research Group, University of Calgary, Calgary, Alberta, Canada.
Hepatology. 2009 Apr;49(4):1267-76. doi: 10.1002/hep.22761.
Natural killer T (NKT) cells and regulatory T cells (Tregs) are both found within the liver and are known to exhibit immune regulatory functions. Hepatic NKT cells are activated early during inflammatory responses and release cytokines, including interferon gamma (IFN-gamma), which we speculated could regulate Treg recruitment to the liver. To examine this, we treated C57BL/6 mice with a specific NKT cell activating ligand alpha galactosyl-C18-ceramide (alphaGal-C18-Cer) and examined the hepatic recruitment of Tregs. We found a time-dependant increase in the hepatic recruitment of Tregs after NKT cell activation, which was absent in NKT cell-deficient mice. Most recruited Tregs expressed interleukin (IL) 10, and to a lesser extent transforming growth factor beta (TGF-beta). Because IFN-gamma induces the production of chemokine (C-X-C motif) ligand 10 (CXCL10), and Tregs can express the cognate receptor for CXCL10 (that is, CXCR3), we considered that CXCL10 might mediate the hepatic recruitment of Tregs after NKT cell activation. Hepatic CXCL10 levels were markedly increased after alphaGal-C18-Cer administration in wild-type but not in NKT cell-deficient mice. Moreover, approximately 50% of Tregs recruited to the liver after alphaGal-C18-Cer administration expressed CXCR3 and CXCR3+ Treg recruitment into the liver was significantly inhibited in IFN-gamma KO mice, and after CXCL10 neutralization. In addition, prevention of CXCR3+ Treg recruitment into the liver enhanced inflammatory effector cell recruitment into the liver after alphaGal-C18-Cer treatment.
These results show that activated NKT cells can induce the hepatic recruitment of Tregs through a cytokine-to-chemokine pathway, which could be relevant in the development of chemokine blocking or NKT cell activating strategies to treat liver diseases.
自然杀伤T(NKT)细胞和调节性T细胞(Tregs)均存在于肝脏中,且已知具有免疫调节功能。肝NKT细胞在炎症反应早期被激活并释放细胞因子,包括干扰素γ(IFN-γ),我们推测其可能调节Tregs向肝脏的募集。为了对此进行研究,我们用特异性NKT细胞激活配体α半乳糖基-C18-神经酰胺(αGal-C18-Cer)处理C57BL/6小鼠,并检测Tregs向肝脏的募集情况。我们发现NKT细胞激活后,Tregs向肝脏的募集呈时间依赖性增加,而在NKT细胞缺陷小鼠中则未出现这种情况。大多数募集到的Tregs表达白细胞介素(IL)10,在较小程度上表达转化生长因子β(TGF-β)。由于IFN-γ可诱导趋化因子(C-X-C基序)配体10(CXCL10)的产生,且Tregs可表达CXCL10的同源受体(即CXCR3),我们认为CXCL10可能介导NKT细胞激活后Tregs向肝脏的募集。在野生型小鼠中给予αGal-C18-Cer后肝CXCL10水平显著升高,而在NKT细胞缺陷小鼠中则未升高。此外,给予αGal-C18-Cer后募集到肝脏的Tregs中约50%表达CXCR3,在IFN-γ基因敲除小鼠中以及CXCL10中和后,CXCR3+ Tregs向肝脏的募集受到显著抑制。此外,在αGal-C18-Cer处理后,阻止CXCR3+ Tregs向肝脏的募集会增强炎症效应细胞向肝脏的募集。
这些结果表明,活化的NKT细胞可通过细胞因子-趋化因子途径诱导Tregs向肝脏的募集,这可能与开发趋化因子阻断或NKT细胞激活策略以治疗肝脏疾病有关。